clinical trial · NCT07258173
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita
Jennifer Keiser·phase2·not yet recruiting·n = 100
Trichuris InfectionTrichurisEmodepsideAlbendazole 400 mg
brief summary
The purpose of this clinical trial is to compare the efficacy and safety of emodepside, with the standard treatment, albendazole, in adolescents (12 years and older) and adults infected with Trichuris incognita.
started
Jan 15, 2026
primary completion
May 15, 2026
completion
May 15, 2026
last updated
Dec 2, 2025
official title
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita: a Phase II, Randomized, Double Blind, Controlled Trial
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol